Bevacizumab-related osteneocrosis of the jaw. [electronic resource]
Producer: 20100322Description: 1121-3 p. digitalISSN:- 0394-6320
- Adenocarcinoma -- drug therapy
- Alveolar Bone Loss -- chemically induced
- Amoxicillin-Potassium Clavulanate Combination -- therapeutic use
- Angiogenesis Inhibitors -- adverse effects
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Bone Neoplasms -- drug therapy
- Chlorhexidine -- administration & dosage
- Humans
- Jaw Diseases -- chemically induced
- Lung Neoplasms -- pathology
- Male
- Middle Aged
- Mouthwashes -- administration & dosage
- Osteonecrosis -- chemically induced
- Pain -- chemically induced
- Tooth Extraction -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.